Amarin Corp Plc (AMRN)

[rmitra]

AmarinInvestor --

>As such it cannot be found (at least as 2000) as obvious that t EPA does not raise LDL.

To be clear, the argument is that Mori does not support the claim that DHA raises LDL more than EPA (or conversely, does not support the claim that EPA raises LDL less than DHA).

That is a subtly different claim than what you stated above, but it's an important distinction, as Mori was unable to reject the null hypothesis that EPA does not raise LDL levels, but was able to reject the null hypothesis that DHA does not raise LDL levels.

Nonetheless, I argue that if it is NOT obvious from Mori that EPA raises LDL LESS than DHA, then Mori should not invalidate the patent.